| Literature DB >> 28199348 |
Kristina E Rudd1,2, Leonard K Tutaryebwa3, T Eoin West1,2.
Abstract
OBJECTIVES: Limited data are available on sepsis in low-resource settings, particularly outside of urban referral centers. We conducted a prospective observational single-center cohort study in May 2013 to assess the presentation, management and outcomes of adult and pediatric patients admitted with sepsis to a community hospital in rural Uganda.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28199348 PMCID: PMC5310912 DOI: 10.1371/journal.pone.0171422
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Patient identification.
Characteristics of patients.
| Variable | Adults | Pediatrics |
|---|---|---|
| 20 (39.2%) | 31 (60.8%) | |
| 11 (55.0%) | 14 (45.2%) | |
| Bantu | 20 (100.0%) | 31 (100.0%) |
| Batwa | 0 (0.0%) | 0 (0.0%) |
| 32 [22–42] | 3 [2–7] | |
| Heart rate | 18 (90.0%) | 19 (61.3%) |
| Respiratory rate | 13 (65.0%) | 29 (93.5%) |
| Temperature | 15 (75.0%) | 31 (100.0%) |
| White blood cell count | 2 (10.0%) | 0 (0.0%) |
| Diabetes | 1 (5.0%) | 0 (0.0%) |
| HIV | 6 (30.0%) | 0 (0.0%) |
| Tuberculosis | 1 (5.0%) | 0 (0.0%) |
| Anorexia | 0 (0.0%) | 10 (32.3%) |
| Cardiopulmonary | 9 (45.0%) | 22 (71.0%) |
| Fever | 15 (75.0%) | 29 (93.5%) |
| Gastrointestinal | 9 (45.0%) | 9 (29.0%) |
| Musculoskeletal | 3 (15.0%) | 2 (6.5%) |
| Neurologic | 13 (65.0%) | 10 (32.3%) |
| Upper respiratory symptoms | 0 (0.0%) | 4 (12.9%) |
aChest pain, cough, dyspnea, hemoptysis.
bAbdominal pain, diarrhea, vomiting.
cArthralgias, back pain, extremity pain, myalgias.
dAltered mental status, dizziness, headache, seizure.
eCoryza, rhinorrhea.
Severity of illness at 24 and 48 hours.
| Variable | Adults | Pediatrics | ||
|---|---|---|---|---|
| 24 hrs | 48 hrs | 24 hrs | 48 hrs | |
| 1 (5.0%) | 0 (0.0%) | 2 (6.5%) | 3 (10%) | |
| Mild, lactate > 2 and ≤ 4 mmol/L | 6 (30.0%) | 8 (50.0%) | 14 (45.2%) | 13 (43.3%) |
| Severe, lactate > 4 mmol/L | 8 (40.0%) | 3 (18.8%) | 5 (16.1%) | 2 (6.7%) |
| 6 (30.0%) | 4 (25.0%) | - | - | |
| 9 (45.0%) | 1 (6.3%) | 11 (35.5%) | 5 (16.7%) | |
| AVPU score, | ||||
| A | 16 (80.0%) | 15 (93.8%) | 20 (64.5%) | 28 (93.3%) |
| V | 2 (10.0%) | 0 (0.0%) | 5 (16.1%) | 0 (0.0%) |
| P | 1 (5.0%) | 0 (0.0%) | 5 (16.1%) | 1 (3.3%) |
| U | 1 (5.0%) | 1 (6.3%) | 1 (3.2%) | 1 (3.3%) |
| 15 [15–15] | 15 [15–15] | 15 [11–15] | 15 [15–15] | |
aMissing value for 1 adult at 24 hrs.
bMissing values for 1 adult at 24 hrs and 1 adult at 48 hrs.
cPediatric blood pressure not available. Missing values for 6 adults at 24 hrs and 2 adults at 48 hrs.
dDue to lack of access to infant-specific oximetry probes, missing values for 6 children at 24 hrs and 7 children at 48 hrs.
Patient management.
| Variable | Adults | Pediatrics | |
|---|---|---|---|
| 16 (80.0%) | 26 (83.9%) | ||
| Amoxicillin | 1 (5.0%) | 1 (3.2%) | |
| Ampicillin | 0 (0.0%) | 8 (25.8%) | |
| Ceftriaxone | 9 (45.0%) | 9 (29.0%) | |
| Chloramphenicol | 3 (15.0%) | 12 (38.7%) | |
| Ciprofloxacin | 1 (5.0%) | 0 (0.0%) | |
| Dicloxacillin | 1 (5.0%) | 0 (0.0%) | |
| Doxycycline | 1 (5.0%) | 0 (0.0%) | |
| Erythromycin | 0 (0.0%) | 1 (3.2%) | |
| Gentamicin | 2 (10.0%) | 9 (29.0%) | |
| Penicillin G | 0 (0.0%) | 1 (3.2%) | |
| Trimethoprim-Sulfamethoxazole | 3 (15.0%) | 0 (0.0%) | |
| 1 (5.0%) | 2 (6.5%) | ||
| Albendazole | 1 (5.0%) | 1 (3.2%) | |
| Mebendazole | 0 (0.0%) | 1 (3.2%) | |
| 8 (40.0%) | 8 (25.0%) | ||
| Artemether | 5 (25.0%) | 8 (25.8%) | |
| Quinine | 5 (25.0%) | 0 (0.0%) | |
| 0 (0.0%) | 0 (0.0%) | ||
| SpO2 < 94% | 4/9 (44.4%) | 9/11 (81.2%) | |
| SpO2 < 90% | 3/3 (100.0%) | 5/5 (100%) | |
| Mild, venous lactate > 2 and ≤4 mmol/L | 3/7 (42.9%) | 8/14 (57.1%) | |
| Severe, venous lactate > 4 mmol/L | 4/8 (50.0%) | 3/5 (60.0%) | |
aIn first 24hr of admission.
bMild hypoperfusion defined as systolic blood pressure < 90mmHg (in adults) or venous lactate > 2 and ≤ 4 mmol/L in the first 24hr of admission. Severe hypoperfusion defined as systolic blood pressure < 70 mmHg (in adults) or venous lactate > 4 mmol/L in the first 24hr of admission. Fluid bolus defined as ≥ 2L isotonic crystalloid in first 24hr in adults and ≥ 20 mL/kg isotonic crystalloid in the first 24hr in pediatrics.
Patient outcomes.
| Variable | Adults | Pediatrics |
|---|---|---|
| Acute otitis media | 0 (0.0%) | 2 (6.5%) |
| Brucellosis | 0 (0.0%) | 1 (3.2%) |
| Encephalitis | 0 (0.0%) | 2 (6.5%) |
| Gastroenteritis | 1 (5.0%) | 1 (3.2%) |
| Idiopathic abdominal pain | 1 (5.0%) | 0 (0.0%) |
| Malaria | 7 (35.0%) | 9 (29.0%) |
| Pharyngotonsillitis | 0 (0.0%) | 1 (3.2%) |
| Pneumonia | 4 (20.0%) | 15 (48.4%) |
| Prostatitis | 1 (5.0%) | 0 (0.0%) |
| Puerperal sepsis | 1 (5.0%) | 0 (0.0%) |
| Sepsis with unspecified source | 3 (15.0%) | 0 (0.0%) |
| Toxoplasmosis | 1 (5.0%) | 0 (0.0%) |
| Tuberculosis | 1 (5.0%) | 0 (0.0%) |
| Typhoid fever | 1 (5.0%) | 1 (3.2%) |
| Viral upper respiratory tract infection | 1 (5.0%) | 7 (22.6%) |
| 2.5 [2.0–3.5] | 2.0 [2.0–4.0] | |
| Home in improved condition | 17 (85.0%) | 30 (96.8%) |
| Home to die | 1 (5.0%) | 0 (0.0%) |
| Died in hospital | 1 (5.0%) | 0 (0.0%) |
| Transferred to other facility | 0 (0.0%) | 1 (3.2%) |
| Left against advice | 1 (5.0%) | 0 (0.0%) |
aThis patient left against medical advice prior to complete evaluation.